Pseudobulbar affect

Search Trials
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Mar 12, 2002
Disease(s):
Multiple Sclerosis
Intervention(s):
AVP-923
Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Mar 8, 2001
Disease(s):
Amyotrophic Lateral Sclerosis
Intervention(s):
AVP-923
Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Pseudobulbar Affect (PBA)
Intervention(s):
Nuedexta (DM 20 mg/Q 10 mg)
PRISM Registry: Pseudobulbar Affect Registry Series
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Mar 6, 2011
Disease(s):
Alzheimer's Disease
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Alzheimer's Disease
Intervention(s):
AVP-923

Connect. Empower. Inspire.